The clinical guidelines for anti-dementia medications recommend that cholinesterase inhibitors are effective for mild to moderate ADRD, while memantine is helpful for moderate to severe ADRD (O'Brien et al., 2017). The gene discussed is BCHE; the disease is dementia.